Safety and Immunogenicity of the Live Attenuated Vaccine QazCOVID-Live Against Coronavirus Infection COVID-19: Pre-Clinical Study Results

Safety and Immunogenicity of the Live Attenuated Vaccine QazCOVID-Live Against Coronavirus Infection COVID-19: Pre-Clinical Study Results

The research conducted in this preclinical study assesses QazCovid-live, a live attenuated COVID-19 vaccine created in Kazakhstan, by conducting preclinical evaluations of safety, immunogenicity, and allergenicity in various animal models, including mice, rats, hamsters, and guinea pigs. The vaccine...

Full description

Saved in:
Bibliographic Details
Main Authors: Lespek Kutumbetov, Balzhan Myrzakhmetova, Aiganym Tussipova, Gulzhan Zhapparova, Talshyngul Tlenchiyeva, Karina Bissenbayeva, Kuanysh Zhapar, Kuandyk Zhugunissov, Sergazy Nurabayev, Aslan Kerimbayev
Format: Article
Language:English
Published: MDPI AG 2024-12-01
Series:Vaccines
Subjects:
QazCOVID-live
live attenuated vaccine
SARS-CoV-2
COVID-19 prevention
preclinical study
vaccine safety
Online Access:https://www.mdpi.com/2076-393X/12/12/1401
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items